Rua Bioscience files documents for October IPO on NZX
The IPO values the medical cannabis company at $70m.
Andrew Bevin
Fri, 25 Sep 2020
East Coast medical cannabis firm Rua Bioscience has filed documents for a 50c a share initial public offering (IPO) on the NZX, valuing the budding company at $70 million post offer.
Founded in 2016 and formerly known as Hikurangi Cannabis Company, Rua hopes to raise $20m through the float,
Want to read more? It's easy.
Choose your best value subscription option
Individual
Group membership
NBR Marketplace
NZ Aviation News
Yearly Premium Online Subscription
NZ$499.00 / yearly
Monthly Premium Online Subscription
NZ$44.95 / monthly
Smartphone Only Subscription
NZ$24.95 / monthly
Premium Group Membership 10 Users
NZ$350+GST / monthly
$35 per user - Pay by monthly credit card debitPremium Group Membership 20 Users
NZ$600+GST / monthly
$30 per user - Pay by monthly credit card debitPremium Group Membership 50 Users
NZ$1250+GST / monthly
$25 per user - Pay by monthly credit card debitPremium Group Membership 100 Users
NZ$1875+GST / monthly
$18.75 per user - Pay by monthly credit card debitYearly Premium Online Subscription + NBR Marketplace
NZ$499.00 / yearly
Aviation News - Monthly
NZ$14.95 / monthly
Already have an account? Login
Andrew Bevin
Fri, 25 Sep 2020
Contact the Writer: andrew@nbr.co.nz
News tip? Question? Typo? Let us know: editor@nbr.co.nz
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Rua Bioscience files documents for October IPO on NZX
Business,
85063